Levi & Korsinsky, LLP

55 Broadway, 10th Floor, New York, NY 10006, US

Recent News

Ongoing Eos Energy Enterprises, Inc. (EOSE) Investigation: Protect Your Rights - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Eos Energy Enterprises, Inc. ("Eos Energy Enterprises, Inc.") (NASDAQ: EOSE) concerning potential violations of the federal securities laws. Levi & Korsinsky, LLP is investigating whether Eos Energy Enterprises may have made materially inaccurate statements to investors regarding its production capacity and product performance. During the Q3 2025 earnings call...

2026-03-09 12:21 AM EDT

ATTENTION PRCT Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation") (NASDAQ: PRCT) concerning potential violations of the federal securities laws. On the Q3 2025 earnings call on November 4, 2025, CFO Kevin Waters reaffirmed the $325.5 million revenue target and stated the company was "maintaining handpiece average selling prices to be approximately $3,200."...

2026-03-09 12:19 AM EDT

Fraud Investigation Opened: Levi & Korsinsky Investigates Alight, Inc. (ALIT) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Alight, Inc. (NYSE: ALIT) ("Alight, Inc.") concerning potential violations of the federal securities laws. Alight's Q4 2025 results landed below the low end of the Company's own full-year 2025 guidance range. On the Q3 2025 earnings call on November 5, 2025, CFO Jeremy Heaton told investors the Company expected full-year 2025 EPS of $0.54 to $0.58 and revenue...

2026-03-09 12:19 AM EDT

Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws. The magnitude of the single-day decline wiped out billions of dollars of shareholder value and represented one of the largest percentage drops in the CRO sector in recent years. Prior to the disclosure, ICLR had traded in a...

2026-03-09 12:17 AM EDT

Did Ralliant Corporation (RAL) Mislead Investors? Levi & Korsinsky Investigates

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ralliant Corporation ("Ralliant Corporation") (NYSE: RAL) concerning potential violations of the federal securities laws. On January 30, 2026--five days before revealing a $1.4 billion goodwill impairment and reduced FY 2026 guidance--Ralliant's board of directors declared a regular quarterly dividend of $0.05 per share. Dividend declarations are widely...

2026-03-09 12:15 AM EDT

Shareholders Alert: Investigation Into Camping World Holdings, Inc. (CWH) - Contact Levi & Korsinsky to Protect Your Rights

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Camping World Holdings, Inc. (NYSE: CWH) ("Camping World Holdings, Inc.") concerning potential violations of the federal securities laws. During the Q3 2025 earnings call on October 29, 2025, CEO Marcus Lemonis stated: "I'm encouraged by our company's financial performance in the quarter, growing adjusted EBITDA by over 40% to $95.7 million." On the same call,...

2026-03-09 12:15 AM EDT

Lost Money on Hub Group, Inc. (HUBG)? Contact Levi & Korsinsky to Protect Your Rights

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Hub Group, Inc. (NASDAQ: HUBG) ("Hub Group, Inc.") concerning potential violations of the federal securities laws. On February 3, 2026, Hub Group reached a 52-week high of $48.96 per share. Three days later, following the accounting error announcement, shares were trading near $37--a loss of roughly $12 per share in a matter of hours. For an investor holding...

2026-03-09 12:13 AM EDT

Investigation Underway: Coty Inc. (COTY) - Contact Levi & Korsinsky Over Securities Law Violations

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Coty Inc. ("Coty Inc.") (NYSE: COTY) concerning potential violations of the federal securities laws. Coty's quarterly loss stands out within the global beauty and personal care sector, an industry that has generally posted resilient consumer demand over the past two years. Peers such as Estée Lauder, L'Oréal, and Shiseido reported stable or improving margins...

2026-03-09 12:13 AM EDT

Potential Securities Fraud: Levi & Korsinsky Investigates Driven Brands Holdings Inc. (DRVN)

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Driven Brands Holdings Inc. ("Driven Brands Holdings Inc.") (NASDAQ: DRVN) concerning potential violations of the federal securities laws. Throughout FY 2025, Driven Brands management reiterated specific financial guidance on successive quarterly earnings calls. On the Q4 2024 call (February 25, 2025), CFO Mike Diamond guided for revenue of $2.05 billion to...

2026-03-09 12:11 AM EDT

Did Gartner, Inc. (IT) Mislead Investors? Levi & Korsinsky Investigates

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. (NYSE: IT) ("Gartner, Inc.") concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that GAAP...

2026-03-09 12:11 AM EDT

Lost Money on Stellantis N.V. (STLA)? Contact Levi & Korsinsky About Investigation

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Stellantis N.V. ("Stellantis N.V.") (NYSE: STLA) concerning potential violations of the federal securities laws. A review of the timeline highlights a sequence of signals that preceded the February 6 disclosure. On January 31, 2026, Wall Street Zen downgraded STLA to Sell. On February 3, Morgan Stanley followed with a downgrade to Equal-Weight, referencing an...

2026-03-09 12:09 AM EDT

Lost Investment in Gossamer Bio, Inc. (GOSS)? Levi & Korsinsky Launches Securities Fraud Investigation

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gossamer Bio, Inc. ("Gossamer Bio, Inc.") (NASDAQ: GOSS) concerning potential violations of the federal securities laws. Seralutinib was Gossamer Bio's lead pipeline candidate and the PROSERA study was the Company's pivotal Phase 3 trial evaluating the drug in pulmonary arterial hypertension. The Company had publicly characterized the PROSERA patient...

2026-03-09 12:08 AM EDT

Securities Investigation: Levi & Korsinsky Investigates Disc Medicine, Inc. (IRON) on Behalf of Investors

New York, New York--(Newsfile Corp. - March 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning potential violations of the federal securities laws. On February 13, 2026, Disc disclosed that the FDA had issued a Complete Response Letter (CRL) for bitopertin, the company's lead therapeutic candidate targeting EPP, a rare genetic disorder characterized by extreme photosensitivity. A CRL...

2026-03-04 1:26 PM EST

Lost Investment in Eos Energy Enterprises, Inc. (EOSE)? Levi & Korsinsky Launches Securities Fraud Investigation

New York, New York--(Newsfile Corp. - March 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Eos Energy Enterprises, Inc. ("Eos Energy Enterprises, Inc.") (NASDAQ: EOSE) concerning potential violations of the federal securities laws. Levi & Korsinsky, LLP is investigating whether Eos Energy Enterprises may have made materially inaccurate statements to investors regarding its production capacity and product performance. During the Q3 2025 earnings call...

2026-03-04 1:24 PM EST

Potential Securities Fraud: Levi & Korsinsky Investigates Ziff Davis, Inc. (ZD)

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ziff Davis, Inc. ("Ziff Davis, Inc.") (NASDAQ: ZD) concerning potential violations of the federal securities laws. Throughout 2025, Ziff Davis highlighted adjusted EBITDA and adjusted diluted EPS as key performance measures in its earnings presentations and calls. On the Q2 2025 earnings call on August 8, 2025, CFO Bret Richter reported adjusted diluted EPS of...

2026-03-03 3:45 PM EST

Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Contact Levi & Korsinsky About Fraud Investigation

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation") (NASDAQ: PRCT) concerning potential violations of the federal securities laws. On the Q3 2025 earnings call on November 4, 2025, CFO Kevin Waters reaffirmed the $325.5 million revenue target and stated the company was "maintaining handpiece average selling prices to be approximately $3,200."...

2026-03-03 3:44 PM EST

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Gossamer Bio, Inc. (GOSS)

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gossamer Bio, Inc. ("Gossamer Bio, Inc.") (NASDAQ: GOSS) concerning potential violations of the federal securities laws. Seralutinib was Gossamer Bio's lead pipeline candidate and the PROSERA study was the Company's pivotal Phase 3 trial evaluating the drug in pulmonary arterial hypertension. The Company had publicly characterized the PROSERA patient...

2026-03-03 3:43 PM EST

Potential Securities Fraud: Levi & Korsinsky Investigates Driven Brands Holdings Inc. (DRVN)

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Driven Brands Holdings Inc. ("Driven Brands Holdings Inc.") (NASDAQ: DRVN) concerning potential violations of the federal securities laws. Throughout FY 2025, Driven Brands management reiterated specific financial guidance on successive quarterly earnings calls. On the Q4 2024 call (February 25, 2025), CFO Mike Diamond guided for revenue of $2.05 billion to...

2026-03-03 3:42 PM EST

Securities Investigation: Levi & Korsinsky Investigates Camping World Holdings, Inc. (CWH) on Behalf of Investors

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Camping World Holdings, Inc. ("Camping World Holdings, Inc.") (NYSE: CWH) concerning potential violations of the federal securities laws. During the Q3 2025 earnings call on October 29, 2025, CEO Marcus Lemonis stated: "I'm encouraged by our company's financial performance in the quarter, growing adjusted EBITDA by over 40% to $95.7 million." On the same call,...

2026-03-03 1:53 PM EST

RAL ACTIVE INVESTIGATION: Lost Money on Ralliant Corporation? Contact Levi & Korsinsky Now

New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ralliant Corporation ("Ralliant Corporation") (NYSE: RAL) concerning potential violations of the federal securities laws. On January 30, 2026--five days before revealing a $1.4 billion goodwill impairment and reduced FY 2026 guidance--Ralliant's board of directors declared a regular quarterly dividend of $0.05 per share. Dividend declarations are widely...

2026-03-02 1:08 AM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us